Equities researchers at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
Shares of NYSE CPHI opened at $0.25 on Tuesday. China Pharma has a 12-month low of $0.17 and a 12-month high of $1.16. The stock has a 50 day simple moving average of $0.23 and a 200-day simple moving average of $0.25. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- Investing In Preferred Stock vs. Common Stock
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
